Brief: NeoGenomics Expands Oncology Testing Reach In The Northeast With Acquisition Of Pathline
10/03/2025 11:06
March 10 (Reuters) - Neogenomics Inc NEO.O: NEOGENOMICS EXPANDS ONCOLOGY TESTING REACH IN THE NORTHEAST WITH ACQUISITION OF PATHLINE NEOGENOMICS INC: SYNERGIES FROM TRANSACTION EXPECTED TO YIELD ANNUAL COST REDUCTIONS, WHICH WILL BE ACCRETIVE TO AEBITDA STARTING IN 2026 Source text: ID:nBw2qLyq7a Further company coverage: NEO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeoGenomics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
NeoGenomics rises after BTIG upgrades to 'buy'
Brief: Neogenomics Announces Executive Leadership And Board Of Directors Succession Plan
Brief: Neogenomics Receives Medicare Coverage For Radar St For Immunotherapy Treatment Response Monitoring